Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $222.24 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $73.22 | 4 | $0 (2018) |
| BAXTER HEALTHCARE | $58.33 | 4 | $0 (2020) |
| PFIZER INC. | $48.50 | 3 | $0 (2018) |
| Kerecis Limited | $26.53 | 1 | $0 (2023) |
| Boston Scientific Corporation | $15.66 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $26.53 | 1 | Kerecis Limited ($26.53) |
| 2020 | $16.25 | 1 | BAXTER HEALTHCARE ($16.25) |
| 2019 | $30.68 | 2 | Boston Scientific Corporation ($15.66) |
| 2018 | $25.56 | 2 | PFIZER INC. ($14.97) |
| 2017 | $123.22 | 7 | Medtronic USA, Inc. ($62.63) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2023 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 GraftGuide, Kerecis Omega3 SurgiClose | Food and Beverage | Cash or cash equivalent | $26.53 | General |
| Category: Wound Care | ||||||
| 02/05/2020 | BAXTER HEALTHCARE | FLOSEAL (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Surgical Care | ||||||
| 06/25/2019 | BAXTER HEALTHCARE | FLOSEAL (Biological) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Surgical Care | ||||||
| 02/01/2019 | Boston Scientific Corporation | SPECTRA WAVEWRITER (Device) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/25/2018 | Medtronic USA, Inc. | AQUAMANTYS (Device) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Advanced Energy Hemostatic Device | ||||||
| 09/01/2018 | PFIZER INC. | THROMBIN (Biological), GELFOAM | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: HEMOSTAT | ||||||
| 12/28/2017 | BAXTER HEALTHCARE | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: Surgical Care | ||||||
| 09/16/2017 | Medtronic USA, Inc. | AQUAMANTYS (Device) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Advanced Energy Hemostatic Device | ||||||
| 09/14/2017 | PFIZER INC. | THROMBIN (Drug), GELFOAM | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: HEMOSTAT | ||||||
| 08/24/2017 | Medtronic USA, Inc. | RESTORE (Device) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/28/2017 | Medtronic USA, Inc. | RESTORE (Device) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/01/2017 | BAXTER HEALTHCARE | Surgical Care - Floseal (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Surgical Care | ||||||
| 03/31/2017 | PFIZER INC. | DYLOJECT (Drug), THROMBIN, SURGISEAL | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: INFLAMMATION;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 231 | 264 | $55,825 | $18,991 |
| 2022 | 2 | 90 | 100 | $46,282 | $13,493 |
| 2021 | 6 | 205 | 223 | $96,363 | $26,886 |
| 2020 | 6 | 170 | 188 | $93,177 | $21,291 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 110 | $16,592 | $7,566 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 44 | $9,632 | $4,237 | 44.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,660 | $2,405 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $6,225 | $2,156 | 34.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 51 | 51 | $7,854 | $1,562 | 19.9% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 13 | 14 | $8,862 | $1,065 | 12.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 57 | 58 | $33,640 | $9,347 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 42 | $12,642 | $4,147 | 32.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 90 | 90 | $52,200 | $15,362 | 29.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 60 | $18,060 | $6,127 | 33.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 27 | $5,481 | $1,901 | 34.7% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Facility | 2021 | 20 | 22 | $13,222 | $1,702 | 12.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $6,058 | $1,346 | 22.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 11 | $1,342 | $448.70 | 33.4% |
| 63047 | Partial removal of middle spine bone with release of spinal cord and/or nerves | Facility | 2020 | 11 | 11 | $35,453 | $7,347 | 20.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 53 | $15,953 | $4,201 | 26.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 29 | 29 | $13,514 | $3,640 | 26.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 47 | $9,541 | $2,587 | 27.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 34 | 34 | $10,302 | $2,410 | 23.4% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Facility | 2020 | 13 | 14 | $8,414 | $1,105 | 13.1% |
About Dr. David Ebelke, M.D
Dr. David Ebelke, M.D is a Orthopaedic Surgery of the Spine healthcare provider based in North Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548317118.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ebelke, M.D has received a total of $222.24 in payments from pharmaceutical and medical device companies, with $26.53 received in 2023. These payments were reported across 13 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($222.24).
As a Medicare-enrolled provider, Ebelke has provided services to 696 Medicare beneficiaries, totaling 775 services with total Medicare billing of $80,660. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery of the Spine
- Location North Kansas City, MO
- Active Since 01/04/2007
- Last Updated 10/30/2023
- Taxonomy Code 207XS0117X
- Entity Type Individual
- NPI Number 1548317118
Products in Payments
- RESTORE (Device) $45.89
- FLOSEAL (Biological) $31.27
- AQUAMANTYS (Device) $27.33
- Kerecis Omega3 SurgiClose (Device) $26.53
- THROMBIN (Drug) $17.44
- Surgical Care - Floseal (Biological) $16.14
- DYLOJECT (Drug) $16.09
- SPECTRA WAVEWRITER (Device) $15.66
- THROMBIN (Biological) $14.97
- TISSEEL (Biological) $10.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.